Holen Sie sich die Stockscreener-App
6.06
2.89%
0.17
Schlusskurs vom Vortag:
$5.89
Offen:
$5.85
24-Stunden-Volumen:
1.02M
Relative Volume:
0.41
Marktkapitalisierung:
$864.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-174.61M
KGV:
-3.0761
EPS:
-1.97
Netto-Cashflow:
$-165.54M
1W Leistung:
+21.32%
1M Leistung:
-30.34%
6M Leistung:
-26.19%
1J Leistung:
-33.84%
1-Tages-Spanne:
$5.76
$6.11
1-Wochen-Bereich:
$4.90
$6.1252
52-Wochen-Spanne:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
Firmenname
89 Bio Inc
Sektor
Branche
Telefon
(415) 432-9270
Adresse
142 SANSOME STREET, SAN FRANCISCO, CA
Vergleichen Sie ETNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
6.06 | 864.23M | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-14 | Eingeleitet | Goldman | Neutral |
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-04-22 | Fortgesetzt | BofA Securities | Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-08-28 | Eingeleitet | UBS | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2022-05-12 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-26 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-19 | Eingeleitet | Raymond James | Strong Buy |
| 2020-09-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-23 | Eingeleitet | BTIG Research | Buy |
| 2020-07-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-12-09 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-12-09 | Eingeleitet | Oppenheimer | Outperform |
| 2019-12-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-12-09 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
89 Bio Inc Aktie (ETNB) Neueste Nachrichten
Federated Hermes Inc. Acquires 4,236 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Geode Capital Management LLC Grows Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio: A Buy With Strong Market Opportunity In MASH And SHTG - Seeking Alpha
89bio’s chief technical operations officer sells $91,207 in stock By Investing.com - Investing.com India
89bio’s chief technical operations officer sells $91,207 in stock - Investing.com
89bio: Primary Asset Targeting 2 Potential Indications; In Late-Stage Development (ETNB) - Seeking Alpha
Vanguard Group Inc. Grows Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Bought by Wellington Management Group LLP - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Bought by American Century Companies Inc. - Defense World
Corebridge Financial Inc. Sells 3,141 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
KLP Kapitalforvaltning AS Purchases New Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Looking For A Good Stock? Let This 89bio Inc (NASDAQ: ETNB) Analysis Help. - stocksregister.com
89bio stock hits 52-week low at $5.96 amid market challenges - Investing.com Canada
89bio stock hits 52-week low at $5.96 amid market challenges By Investing.com - Investing.com South Africa
Teacher Retirement System of Texas Has $191,000 Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Swiss National Bank Grows Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Certain Warrants of 89bio, Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2025. - MarketScreener
Raymond James Financial Inc. Invests $2.95 Million in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Certain Options of 89bio, Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2025. - marketscreener.com
Are 89bio Inc (NASDAQ: ETNB) Analysts Predicting A Spike? - Stocks Register
Victory Capital Management Inc. Acquires 1,437 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
PNC Financial Services Group Inc. Increases Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (NASDAQ:ETNB) Given Sell (D-) Rating at Weiss Ratings - Defense World
89bio, Inc. (NASDAQ:ETNB) Stock Holdings Lifted by Bank of New York Mellon Corp - Defense World
89bio, Inc. (NASDAQ:ETNB) Receives $27.56 Average Target Price from Analysts - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Sold by Steward Partners Investment Advisory LLC - Defense World
89bio (NASDAQ:ETNB) Research Coverage Started at The Goldman Sachs Group - Defense World
Citigroup Initiates Coverage on 89bio (NASDAQ:ETNB) - Defense World
Goldman Sachs starts 89bio stock with neutral, $11 target By Investing.com - Investing.com Australia
Goldman Sachs Initiates Coverage of 89bio (ETNB) with Neutral Recommendation - Nasdaq
Goldman Sachs Initiates Coverage on 89bio With Neutral Rating, $11 Price Target -March 14, 2025 at 07:21 am EDT - Marketscreener.com
Goldman Sachs starts 89bio stock with neutral, $11 target - Investing.com India
89bio initiated with a Neutral at Goldman Sachs - TipRanks
89bio (ETNB) Receives a New Rating from Goldman Sachs - The Globe and Mail
Commit To Buy 89bio At $7.50, Earn 25.1% Annualized Using Options - Nasdaq
Citigroup Initiates Coverage of 89bio (ETNB) with Buy Recommendation - Nasdaq
Citigroup Initiates 89bio Inc at Buy With $25 Price Target -March 13, 2025 at 07:13 am EDT - Marketscreener.com
89bio initiated with a Buy at Citi - TipRanks
Bears are Losing Control Over 89BIO (ETNB), Here's Why It's a 'Buy' Now - Yahoo Finance
Time nigh for I&I? Key data points ahead - BioWorld MedTech
89bio Inc (NASDAQ: ETNB) Is On The Fall - Stocks Register
89bio (NASDAQ:ETNB) Earns Sell (D-) Rating from Weiss Ratings - Defense World
Rhumbline Advisers Has $1.02 Million Stock Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
MASH field still hot as Boehringer axes $870M deal with Yuhan - BioWorld MedTech
89bio FY2025 EPS Forecast Increased by Cantor Fitzgerald - Defense World
Boston Pharma Plays Catch Up To Akero, 89bio In MASH - Citeline News & Insights
Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
New York State Common Retirement Fund Has $128,000 Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio to Participate in the Leerink Partners Global Healthcare Conference - The Manila Times
Finanzdaten der 89 Bio Inc-Aktie (ETNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):